{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T21:55:40Z","timestamp":1790978140770,"version":"4.1.0"},"reference-count":40,"publisher":"Wiley","issue":"3","license":[{"start":{"date-parts":[[2003,2,6]],"date-time":"2003-02-06T00:00:00Z","timestamp":1044489600000},"content-version":"vor","delay-in-days":5,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Br J Haematol"],"published-print":{"date-parts":[[2003,2]]},"abstract":"<jats:p><jats:bold>Summary.<\/jats:bold> The expression of apoptosis\u2010related genes <jats:italic>BCL2<\/jats:italic>, <jats:italic>BAX, BCL2L1, BCL2A1, MCL1, DAPK1<\/jats:italic> and <jats:italic>MYC<\/jats:italic> was studied by quantitative real\u2010time polymerase chain reaction on total RNA samples from patients with acute lymphoblastic leukaemia (ALL, <jats:italic>n<\/jats:italic>\u2003=\u200316), acute myeloid leukaemia (AML, <jats:italic>n<\/jats:italic>\u2003=\u200327), chronic myeloid leukaemia (CML, <jats:italic>n<\/jats:italic>\u2003=\u200312), mantle cell lymphoma (MCL, <jats:italic>n<\/jats:italic>\u2003=\u200319) and chronic lymphoid leukaemia (CLL, <jats:italic>n<\/jats:italic>\u2003=\u200332). <jats:italic>BCL2<\/jats:italic>, <jats:italic>BAX<\/jats:italic>, <jats:italic>BCL2A1, MCL1, DAPK1<\/jats:italic> and <jats:italic>MYC<\/jats:italic> were overexpressed in all patient groups. <jats:italic>BCL2L1<\/jats:italic> was underexpressed in CLL and CML, but not in AML, ALL and MCL. <jats:italic>MCL1<\/jats:italic> levels were significantly higher in CD13 and CD33\u2010positive ALL, and in CD56\u2010positive AML samples. <jats:italic>BCL2, BCL2L1, BCL2A1<\/jats:italic> and <jats:italic>MCL1<\/jats:italic> were overexpressed and <jats:italic>DAPK1<\/jats:italic> was underexpressed in CLL samples with a 11q23 deletion. <jats:italic>MYC<\/jats:italic> overexpression was significantly associated with shorter overall survival in MCL (<jats:italic>P<\/jats:italic>\u2003&lt;\u20030\u00b701). AML patients with a normal karyotype showed a higher frequency of <jats:italic>BCL2A1<\/jats:italic> overexpression (<jats:italic>P<\/jats:italic>\u2003&lt;\u20030\u00b7001) than those with an abnormal karyotype.<\/jats:p>","DOI":"10.1046\/j.1365-2141.2003.04121.x","type":"journal-article","created":{"date-parts":[[2003,3,11]],"date-time":"2003-03-11T06:50:48Z","timestamp":1047365448000},"page":"434-441","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":84,"title":["Abnormal expression of apoptosis\u2010related genes in haematological malignancies: overexpression of MYC is poor prognostic sign in mantle cell lymphoma"],"prefix":"10.1111","volume":"120","author":[{"given":"B\u00e1lint","family":"Nagy","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tuija","family":"Lund\u00e1n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcelo L.","family":"Larramendy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Aalto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tarja","family":"Niini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henrik","family":"Edgren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Ferrer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juhani","family":"Vilpo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erkki","family":"Elonen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kim","family":"Vettenranta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaarle","family":"Franssila","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sakari","family":"Knuutila","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2003,2,6]]},"reference":[{"key":"e_1_2_22_2_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.leu.2402282"},{"key":"e_1_2_22_3_1","doi-asserted-by":"publisher","DOI":"10.1126\/science.281.5381.1322"},{"key":"e_1_2_22_4_1","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M909826199"},{"key":"e_1_2_22_5_1","first-page":"4365","article-title":"Increased number of chromosomal imbalances and high\u2010level DNA amplifications in mantle cell lymphoma are associated with blastoid variants","volume":"93","author":"Bea S.","year":"1999","journal-title":"Blood"},{"key":"e_1_2_22_6_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.leu.2402272"},{"key":"e_1_2_22_7_1","first-page":"3562","article-title":"The International Prognostic Index correlates to survival in patients with aggressive lymphoma in relapse: analysis of the PARMA trial. PARMA Group","volume":"92","author":"Blay J.","year":"1998","journal-title":"Blood"},{"key":"e_1_2_22_8_1","doi-asserted-by":"publisher","DOI":"10.1016\/0092-8674(93)90508-N"},{"key":"e_1_2_22_9_1","doi-asserted-by":"publisher","DOI":"10.1146\/annurev.immunol.16.1.395"},{"key":"e_1_2_22_10_1","doi-asserted-by":"publisher","DOI":"10.1146\/annurev.ge.20.120186.002045"},{"key":"e_1_2_22_11_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.leu.2402416"},{"key":"e_1_2_22_12_1","first-page":"3879","article-title":"Bfl\u20101, a bcl\u20102 homologue, suppresses p53\u2010induced apoptosis and exhibits potent cooperative transforming activity","volume":"56","author":"D'Sa\u2010Eipper C.","year":"1996","journal-title":"Cancer Research"},{"key":"e_1_2_22_13_1","doi-asserted-by":"publisher","DOI":"10.1101\/gad.9.1.15"},{"key":"e_1_2_22_14_1","first-page":"250","article-title":"Prognostic significance of CD56 antigen expression in acute myeloid leukemia","volume":"87","author":"Di Bona E.","year":"2002","journal-title":"Haematologica"},{"key":"e_1_2_22_15_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2141.1996.d01-1856.x"},{"key":"e_1_2_22_16_1","first-page":"2322","article-title":"The importance of diagnostic cytogenetics on outcome in AML: analysis of 1612 patients entered into the MRC AML 10 trial. The Medical Research Council Adult and Children's Leukaemia Working Parties","volume":"92","author":"Grimwade D.","year":"1998","journal-title":"Blood"},{"key":"e_1_2_22_17_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.leu.2401599"},{"key":"e_1_2_22_18_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V98.3.787"},{"key":"e_1_2_22_19_1","doi-asserted-by":"publisher","DOI":"10.1038\/361365a0"},{"key":"e_1_2_22_20_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V91.3.991"},{"key":"e_1_2_22_21_1","first-page":"1693s","article-title":"BCL\u20102 gene family and the regulation of programmed cell death","volume":"59","author":"Korsmeyer S.J.","year":"1999","journal-title":"Cancer Research"},{"key":"e_1_2_22_22_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.90.8.3516"},{"key":"e_1_2_22_23_1","first-page":"1309","article-title":"Immunohistochemical analysis of Mcl\u20101 protein in human tissues. Differential regulation of Mcl\u20101 and Bcl\u20102 protein production suggests a unique role for Mcl\u20101 in control of programmed cell death in vivo","volume":"146","author":"Krajewski S.","year":"1995","journal-title":"American Journal of Pathology"},{"key":"e_1_2_22_24_1","first-page":"568","article-title":"Overexpression of translocation\u2010associated fusion genes of FGFRI, MYC, NPMI, DEK and BCL2, but absence of translocations in acute myeloid leukemia: a microarray analysis","volume":"87","author":"Larramendy M.L.","year":"2002","journal-title":"Haematologica"},{"key":"e_1_2_22_25_1","doi-asserted-by":"crossref","first-page":"4415","DOI":"10.1182\/blood.V89.12.4415","article-title":"Interleukin 13 in combination with CD40 ligand potently inhibits apoptosis in human B lymphocytes: upregulation of Bcl\u2010xL and Mcl\u20101","volume":"89","author":"Lomo J.","year":"1997","journal-title":"Blood"},{"key":"e_1_2_22_26_1","doi-asserted-by":"publisher","DOI":"10.1146\/annurev.bi.61.070192.004113"},{"key":"e_1_2_22_27_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V91.8.2991.2991_2991_2997"},{"key":"e_1_2_22_28_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2141.1999.01257.x"},{"key":"e_1_2_22_29_1","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1182\/blood.V96.1.275.013k43_275_281","article-title":"Bcl\u2010X (L) is upregulated by HTLV\u2010I and HTLV\u2010II in vitro and in ex vivo ATLL samples","volume":"96","author":"Nicot C.","year":"2000","journal-title":"Blood"},{"key":"e_1_2_22_30_1","doi-asserted-by":"publisher","DOI":"10.1016\/0092-8674(93)90509-O"},{"key":"e_1_2_22_31_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2141.1996.d01-1927.x"},{"key":"e_1_2_22_32_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.onc.1202591"},{"key":"e_1_2_22_33_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.1999.17.9.2941"},{"key":"e_1_2_22_34_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9440(10)64779-7"},{"key":"e_1_2_22_35_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.onc.1202725"},{"key":"e_1_2_22_36_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V98.13.3541"},{"key":"e_1_2_22_37_1","doi-asserted-by":"publisher","DOI":"10.1038\/20959"},{"key":"e_1_2_22_38_1","doi-asserted-by":"publisher","DOI":"10.1128\/MCB.19.8.5659"},{"key":"e_1_2_22_39_1","doi-asserted-by":"publisher","DOI":"10.1126\/science.3874430"},{"key":"e_1_2_22_40_1","first-page":"908","article-title":"Deletions at 11q23 in different lymphoma subtypes","volume":"85","author":"Zhu Y.","year":"2000","journal-title":"Haematologica"},{"key":"e_1_2_22_41_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2141.2002.03931.x"}],"container-title":["British Journal of Haematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1046%2Fj.1365-2141.2003.04121.x","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1046\/j.1365-2141.2003.04121.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,16]],"date-time":"2023-10-16T04:17:29Z","timestamp":1697429849000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1046\/j.1365-2141.2003.04121.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2003,2]]},"references-count":40,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2003,2]]}},"alternative-id":["10.1046\/j.1365-2141.2003.04121.x"],"URL":"https:\/\/doi.org\/10.1046\/j.1365-2141.2003.04121.x","archive":["Portico"],"relation":{},"ISSN":["0007-1048","1365-2141"],"issn-type":[{"value":"0007-1048","type":"print"},{"value":"1365-2141","type":"electronic"}],"subject":[],"published":{"date-parts":[[2003,2]]},"assertion":[{"value":"2003-02-06","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}